Walder Wyss advised Merck on the deal, and Baker Mckenzie advised Chord Therapeutics SA. Merck entered into an agreement to acquire Chord Therapeutics SA, a Swiss-based...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised lead investor Revaia on the deal. Wenger Vieli advised Frontify. Frontify AG, a leading provider of brand management software, raised an additional USD...
You must be a Standard 1 Year member to access this content.
CMS advised the shareholders of Quartal on all legal matters of the transaction. Walder Wyss Ltd. advised PureFacts Financial Solutions. McCarthy Tétrault LLP advised The Bank...
You must be a Standard 1 Year member to access this content.
